Rxcurve
HCPCS J9314 · per 10 MG

Inj pemetrexed (teva) 10mg

Products billed under this code include Pemetrexed.

Payment limit per 10 MG, by effective quarter, 2Q23 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J9314

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Pemetrexed Teva Pharmaceuticals USA, Inc. 00480-4514-01 50 $549.30
Pemetrexed Teva Pharmaceuticals USA, Inc. 00480-4515-01 100 $1,098.60
Pemetrexed Teva Pharmaceuticals USA, Inc. 00480-4516-01 10 $109.86

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $10.986 $0.00 10 MG Inj pemetrexed (teva) 10mg v1, posted September 17, 2026
3Q26 $10.986 $0.00 10 MG Inj pemetrexed (teva) 10mg v1, posted September 15, 2026
2Q26 $10.986 −$4.348 10 MG Inj pemetrexed (teva) 10mg v1, posted September 15, 2026
1Q26 $15.334 −$0.209 10 MG Inj pemetrexed (teva) 10mg v1, posted September 15, 2026
4Q25 $15.543 +$11.752 10 MG Inj pemetrexed (teva) 10mg v1, posted September 8, 2026
3Q25 $3.791 −$4.579 10 MG Inj pemetrexed (teva) 10mg v1, posted March 10, 2026
2Q25 $8.37 +$1.235 10 MG Inj pemetrexed (teva) 10mg v1, posted March 10, 2026
1Q25 $7.135 +$1.616 10 MG Inj pemetrexed (teva) 10mg v1, posted December 19, 2025
4Q24 $5.519 −$5.476 10 MG Inj pemetrexed (teva) 10mg v1, posted June 11, 2025
3Q24 $10.995 +$1.035 10 MG Inj pemetrexed (teva) 10mg v1, posted June 11, 2025
2Q24 $9.96 – 10 MG Inj pemetrexed (teva) 10mg v1, posted March 11, 2025
3Q23 $12.30 −$1.102 10 MG Inj pemetrexed (teva) 10mg v1, posted June 5, 2024
2Q23 $13.402 – 10 MG Inj pemetrexed (teva) 10mg v1, posted February 23, 2024

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files